New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population

Changhai Hospital2,000 enrolled

Overview

This is a prospective, multicenter, observational study, aiming at comparing the Safety and effectiveness among the different surgical treatment of unruptured intracranial aneurysms in China, so as to improve the diagnosis and treatment of unruptured intracranial aneurysms.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Unruptured Cerebral Aneurysm Treatment Strategy

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patients diagnosed with unruptured intracranial saccular aneurysm on CTA, MRA or DSA. * patients willing to participate in this clinical trial and attach to regular follow up. Exclusion Criteria: * intracranial aneurysm correlating to AVM. * intracranial non-saccular aneurysm. * the rupture or unrpture of the aneurysm confirmed on CTA、MRA or DSA. * patients unwilling to participate in this clinical trial and attach to regular follow up.

Locations (1)

Changhai Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Outcomes

Primary Outcomes

mortality and disability

the rate of death and disable

Time frame: through study completion, an average of 1 year

Secondary Outcomes

recurrence rate

Time frame: 1 month, 6 months and 1 year after surgery;

progression of disease

enlarge or ruptured of the aneurysm

Time frame: 1 month, 6 months and 1 year after conservative treatment；

Central Contacts

Pengfei Yang, MD

CONTACT

+86 15921196312 15921196312@163.com

Hongjian Zhang, MD

CONTACT

+86 13961616656 chzhanghj2012@me.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.